3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Prostatic Neoplasms
13
Breast Neoplasms
12
Obesity
8
Colorectal Neoplasms
7
Ovarian Neoplasms
5
Motor Activity
5
Malnutrition
5
Polycystic Ovary Syndrome
4
Pancreatic Neoplasms
4
Overweight
3
Multiple Myeloma
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Weight Loss
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Insulin Resistance
2
Head and Neck Neoplasms
2
Glioblastoma
2
Fatigue
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Interventions
lutetium Lu 177 dotatate
29
Everolimus
19
Temozolomide
11
gallium Ga 68 dotatate
10
Nivolumab
10
Magnetic Resonance Spectroscopy
10
Capecitabine
9
pembrolizumab
8
lanreotide
8
Positron Emission Tomography Computed Tomography
8
cabozantinib
7
3-Iodobenzylguanidine
7
177Lu-octreotide, DOTA(0)-Tyr(3)-
7
Somatostatin
6
90Y-octreotide, DOTA-Tyr(3)-
6
telotristat ethyl
5
lenvatinib
5
Octreotide
5
Lutetium-177
5
Ga(III)-DOTATOC
5
Fluorodeoxyglucose F18
5
Carboplatin
5
avelumab
4
Positron-Emission Tomography
4
Ipilimumab
4
Bevacizumab
4
surufatinib
3
pasireotide
3
fluorodopa F 18
3
copper dotatate CU-64
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroendocrine Tumors
×
Diet Therapy
×
Clear all
NCT02481804
2024-05-06
DIVIT-pilot
University Medical Center Groningen
Phase NA
Completed
15 enrolled